Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study.

No Thumbnail Available
Authors
Shore, Angela
Colhoun, H M
Natali, A
Palombo, C
Östling, G
Aizawa, Kunihiko
Kennbäck, C
Casanova, Francesco
Persson, M
Gooding, Kim M.
Journal
Journal of internal medicine
Type
Journal Article
Research Support, Non-U.S. Gov't
Publisher
Wiley
Rights
Archived with thanks to Journal of internal medicine
There is a need to develop and validate surrogate markers of cardiovascular disease (CVD) in subjects with diabetes. The macrovascular changes associated with diabetes include aggravated atherosclerosis, increased arterial stiffness and endothelial dysfunction. The aim of this study was to determine which of these factors is most strongly associated with clinically manifest cardiovascular events.
Citation
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study. 2015, 278 (3):291-302 J. Intern. Med.
Note